Molina Healthcare, Inc. (MOH)
NYSE: MOH · IEX Real-Time Price · USD
288.36
+0.62 (0.22%)
At close: Jul 19, 2024, 4:00 PM
295.00
+6.64 (2.30%)
Pre-market: Jul 22, 2024, 7:36 AM EDT

Molina Healthcare Revenue

Molina Healthcare had revenue of $35.85B in the twelve months ending March 31, 2024, with 10.82% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $9.93B with 21.87% year-over-year growth. In the year 2023, Molina Healthcare had annual revenue of $34.07B with 6.56% growth.

Revenue (ttm)
$35.85B
Revenue Growth
+10.82%
P/S Ratio
0.47
Revenue / Employee
$1,991,889
Employees
18,000
Market Cap
16.90B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202334.07B2.10B6.56%
Dec 31, 202231.97B4.20B15.13%
Dec 31, 202127.77B8.35B42.98%
Dec 31, 202019.42B2.59B15.41%
Dec 31, 201916.83B-2.06B-10.91%
Dec 31, 201818.89B-993.00M-4.99%
Dec 31, 201719.88B2.10B11.82%
Dec 31, 201617.78B3.60B25.42%
Dec 31, 201514.18B4.51B46.66%
Dec 31, 20149.67B3.08B46.71%
Dec 31, 20136.59B674.79M11.41%
Dec 31, 20125.91B1.37B30.26%
Dec 31, 20114.54B454.29M11.12%
Dec 31, 20104.09B416.62M11.35%
Dec 31, 20093.67B556.99M17.90%
Dec 31, 20083.11B619.91M24.87%
Dec 31, 20072.49B487.46M24.31%
Dec 31, 20062.00B354.94M21.51%
Dec 31, 20051.65B474.79M40.40%
Dec 31, 20041.18B381.72M48.10%
Dec 31, 2003793.54M149.38M23.19%
Dec 31, 2002644.16M140.31M27.85%
Dec 31, 2001503.86M174.42M52.95%
Dec 31, 2000329.43M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Baxter International 14.89B
Labcorp Holdings 12.30B
Quest Diagnostics 9.29B
Incyte 3.77B
The Cooper Companies 3.73B
Waters 2.91B
BeiGene 2.76B
United Therapeutics 2.50B
Revenue Rankings